Category: Clinical Breakthroughs
-
Investigating Clinical Trends in HIV-Associated Cancers
Two HIV-associated cancers are less common since the advent of antiretroviral therapy, but still occur in patients with controlled HIV, according to a Northwestern Medicine study.
-
Short Episodes of Atrial Fibrillation Don’t Increase Stroke Risk
Patients with pacemakers or defibrillators who experience only short episodes of atrial fibrillation are not at an increased risk for stroke, according to a Northwestern Medicine study.
-
New Drug Clears Atopic Dermatitis in Clinical Trials
Nearly 40 percent of patients with atopic dermatitis saw their disease completely or almost completely cleared with a new drug called dupilumab, according to a Northwestern Medicine clinical trial.
-
Gene Signature Predicts Response to Radiation Therapy
In a retrospective study, scientists developed and validated a gene expression signature that can predict which patients with prostate cancer will benefit most from postoperative radiotherapy.
-
Longitudinal Study Links Air Pollution With Cardiovascular Disease Risk
New research suggests increased concentrations of air pollution are associated with progression of cardiovascular disease.
-
Physical Activity Helps Older Adults Maintain Mobility
A regular physical activity program reduced the amount of time older adults spent with a major mobility disability, according to recent research.
-
New Consortium Will Capture How Environmental Exposures Impact Child Health
Northwestern University has been awarded a grant from the National Institutes of Health to help scientists across the country study how environmental factors influence health outcomes for children.
-
Leveraging Big Data to Improve Patient Care in Cardiology
Northwestern Medicine scientists utilized a data science approach to develop more efficient methodology that can be used to inform a wide variety of quality improvement strategies in clinical practices.
-
RNA Test Helps Identify Bacterial Infections in Infants
Northwestern Medicine scientists evaluated whether an RNA biosignature could distinguish if infants 60 days or younger with fever had a serious bacterial infection.
-
Untangling the Financial Dynamics of Pharmaceutical Innovation
Victor Roy, an MD/PhD candidate, described the tension between pharmaceutical innovation and affordability in a recently published analysis.
